Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2004
Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damageAndrew Webb, Richard Bond, Peter McLean, et al.
Molecular and Cellular Biochemistry|March 10, 2009
The alternative splice variant of DAPK-1, s-DAPK-1, induces proteasome-independent DAPK-1 destabilizationYao Lin, Craig Stevens, Ben Harrison, et al.
Current Opinion in Pharmacology|April 1, 2014
Ligand bias prevents class equality among beta-blockersVaidehi J Thanawala, Gloria S Forkuo, Wayne Stallaert, et al.
Cancer Letters|November 2, 2010
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastasesMichelle L Varney, Seema Singh, Aihua Li, et al.
The Journal of Biological Chemistry|November 1, 2008
Peptide combinatorial libraries identify TSC2 as a death-associated protein kinase (DAPK) death domain-binding protein and reveal a stimulatory role for DAPK in mTORC1 signalingCraig Stevens, Yao Lin, Ben Harrison, et al.
Human Psychopharmacology|March 3, 2004
Effects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humansPradeep J Nathan, Sally Tanner, Jenny Lloyd, et al.
The Journal of Biological Chemistry|January 16, 2008
DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbingBen Harrison, Michaela Kraus, Lindsay Burch, et al.
Applied and Environmental Microbiology|December 8, 2005
Molecular characterization of Clostridium perfringens isolates from humans with sporadic diarrhea: evidence for transcriptional regulation of the beta2-toxin-encoding geneBen Harrison, Deepa Raju, Helen S Garmory, et al.
The FEBS Journal|April 22, 2008
An alternative transcript from the death-associated protein kinase 1 locus encoding a small protein selectively mediates membrane blebbingYao Lin, Craig Stevens, Roman Hrstka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2009
Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesisSeema Singh, Anguraj Sadanandam, Kalyan C Nannuru, et al.
Pageof 5